This case-study-based discussion focuses on valuation for companies significantly impacted by COVID-19. The panelists discuss recent cases where the market and business uncertainty caused by the pandemic led to unpredictable or unexpected valuation outcomes. Further consideration is given as to how these outcomes might (or might not) be relevant going forward.